Synthes Confirms Potential $20B Acquisition By J&J

Law360, New York (April 18, 2011, 4:14 PM EDT) -- Synthes Inc. confirmed Monday that it is in talks with New Jersey-based medical device giant Johnson & Johnson about a merger that could value the Swiss-based medical device maker at $20 billion.

A purchase of Synthes, with its 2010 net sales of more than $3.6 billion, likely is seen by J&J as a method of quickly boosting earnings after a year in which the pharmaceutical giant saw drops in sales and earnings growth.

Over the last 10 years Synthes has increased its revenues from $900 million...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.